Sangamo Biosciences (SGMO) R&D EVP Resigns

October 19, 2016 7:47 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Sangamo Biosciences (Nasdaq: SGMO) disclosed the following in a U.S. SEC filing on Tuesday:

Item 5.02. - Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

On October 12, 2016, Geoffrey Nichol, M.B., Ch.B., notified Sangamo BioSciences, Inc. of his resignation as Executive Vice President, Research and Development effective October 25, 2016.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Management Changes

Add Your Comment